Category: 217192-22-8

Epoxy compounds usually have stronger nucleophilic ability, because the alkyl group on the oxygen atom makes the bond angle smaller, which makes the lone pair of electrons react more dissimilarly with the electron-deficient system. Compound: (4-(Pyridin-4-yl)phenyl)methanol, is researched, Molecular C12H11NO, CAS is 217192-22-8, about Linking [2]rotaxane wheels to create a new type of metal organic rotaxane framework.Application In Synthesis of (4-(Pyridin-4-yl)phenyl)methanol.

Three new [2]rotaxanes with aromatic nitrogen donors appended to the crown ether wheel were synthesized by the combination of tetraarom. nitrogen group substituted dibenzo-24-crown-8 ether wheel (tetraarom. nitrogen group = 8-hydroxyquinoline, 3-pyridyl, 4-pyridyl) and a dicationic 1,2-bis(pyridinium)ethane axle and used as ligands to coordinate Cd(II) ions. One of these yields a new type of 2-periodic, metal organic rotaxane framework in which the wheel rather than the axle was used to link the metal nodes. The cadmium complexes and reactant precursor were characterized via x-ray determination

I hope my short article helps more people learn about this compound((4-(Pyridin-4-yl)phenyl)methanol)Application In Synthesis of (4-(Pyridin-4-yl)phenyl)methanol. Apart from the compound(217192-22-8), you can read my other articles to know other related compounds.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Name: (4-(Pyridin-4-yl)phenyl)methanol. The reaction of aromatic heterocyclic molecules with protons is called protonation. Aromatic heterocycles are more basic than benzene due to the participation of heteroatoms. Compound: (4-(Pyridin-4-yl)phenyl)methanol, is researched, Molecular C12H11NO, CAS is 217192-22-8, about Regioselective Catenation of Dinuclear Palladium and Platinum Metallocycles Promoted by π···π Interactions. Author is Blanco, Victor; Abella, Dolores; Pia, Elena; Platas-Iglesias, Carlos; Peinador, Carlos; Quintela, Jose M..

Dinuclear metallocycles were assembled from an L-shaped bidentate ligand based on 4,4′-bipyridine and Pd or Pt square-planar cis complexes. The Pd (4a,b) or Pt (5a,b) square metallocycles, I6+ and II6+ (M = Pd, Pt, as NO3- (a) and PF6- (b) salts, resp.), were obtained as 1:1 regioisomeric mixtures depending on which pair of coordinative N atoms binds to the metal center. The squares display a π-deficient cavity suitable to incorporate two π-donor aromatic systems. Therefore, the reaction with macrocyclic polyethers (BPP34C10 or DN38C10) resulted in the regioselective self-assembly of the [3]catenanes 4a(BPP34C10 or DN38C10)2·6PF6 and 5a(BPP34C10 or DN38C10)2·6PF6 because only macrocycles 4a and 5a present the correct disposition of the π-deficient aromatic systems to maximize the π···π stacking interactions. Single-crystal x-ray analyses of [3]catenanes revealed that the structures are addnl. stabilized by [C-H···O], [N-H···O] bonds and [C-H···π] interactions. The 1:2 inclusion complexes of metallocycles were prepared by self-assembly of three components: the ligand 1-(4-(pyridin-4-yl)benzyl)-4,4′-bipyridin-1-ium, a square planar complex M(en)(NO3)2 (M = Pd or Pt, en = ethylenediamine), and a dioxoarom. guest in a 2:2:2 ratio. The comparative study of the formation of 1:2 inclusion complexes has allowed the authors to conclude that the π···π interactions between the host and guests are responsible for the observed regioselectivity.

I hope my short article helps more people learn about this compound((4-(Pyridin-4-yl)phenyl)methanol)Name: (4-(Pyridin-4-yl)phenyl)methanol. Apart from the compound(217192-22-8), you can read my other articles to know other related compounds.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

The three-dimensional configuration of the ester heterocycle is basically the same as that of the carbocycle. Compound: (4-(Pyridin-4-yl)phenyl)methanol(SMILESS: OCC1=CC=C(C2=CC=NC=C2)C=C1,cas:217192-22-8) is researched.Reference of 1-(Bromomethyl)-4-ethylbenzene. The article 《Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl》 in relation to this compound, is published in Journal of Medicinal Chemistry. Let’s take a look at the latest research on this compound (cas:217192-22-8).

EP2 receptor agonists are expected to be effective ocular hypotensive agents; however, it has been suggested that agonism to other EP receptor subtypes may lead to undesirable effects. Through medicinal chem. efforts, we identified a scaffold bearing a (pyridin-2-ylamino)acetic acid moiety as a promising EP2-selective receptor agonist. (6-((4-(Pyrazol-1-yl)benzyl)(pyridin-3-ylsulfonyl)aminomethyl)pyridin-2-ylamino)acetic acid 13ax (omidenepag, OMD) exerted potent and selective activity toward the human EP2 receptor (h-EP2). Low doses of omidenepag iso-Pr (OMDI), a prodrug of 13ax, lowered intraocular pressure (IOP) in ocular normotensive monkeys. OMDI was selected as a clin. candidate for the treatment of glaucoma.

Here is just a brief introduction to this compound(217192-22-8)SDS of cas: 217192-22-8, more information about the compound((4-(Pyridin-4-yl)phenyl)methanol) is in the article, you can click the link below.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Computed Properties of C12H11NO. So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic. Compound: (4-(Pyridin-4-yl)phenyl)methanol, is researched, Molecular C12H11NO, CAS is 217192-22-8, about In situ-prepared homogeneous supramolecular organic framework drug delivery systems (sof-DDSs): Overcoming cancer multidrug resistance and controlled release.

Water-soluble three-dimensional porous supramol. organic frameworks (SOFs) have been demonstrated as a new generation of homogeneous polycationic platforms for anti-cancer drug delivery. The new SOF drug delivery systems (sof-DDSs) can adsorb dianionic pemetrexed (PMX), a clin. used chemotherapeutic agent instantaneously upon dissolving in water, which is driven by both electrostatic attraction and hydrophobicity. The in situ-prepared PMX@SOFs are highly stable and can avoid important release of the drug during plasm circulation and overcome the multidrug resistance of human breast MCF-7/Adr cancer cells to enter the cancer cells. Acidic microenvironment of cancer cells promotes the release of the drug in cancer cells. Both in vitro and in vivo studies have revealed that sof-DDSs considerably improve the treatment efficacy of PMX, leading to 6-12-fold reduction of the IC50 values, as compared with that of PMX alone. The new drug delivery strategy omits the loading process required by most of reported nanoparticle-based delivery systems and thus holds promise for future development of low-cost drug delivery systems.

If you want to learn more about this compound((4-(Pyridin-4-yl)phenyl)methanol)Computed Properties of C12H11NO, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(217192-22-8).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Holvey, Rhian S.; Valkov, Eugene; Neal, David; Stewart, Murray; Abell, Chris researched the compound: (4-(Pyridin-4-yl)phenyl)methanol( cas:217192-22-8 ).Safety of (4-(Pyridin-4-yl)phenyl)methanol.They published the article 《Selective Targeting of the TPX2 Site of Importin-α Using Fragment-Based Ligand Design》 about this compound( cas:217192-22-8 ) in ChemMedChem. Keywords: TPX importin protein interaction inhibitor; crystal structure; cancer; fragment-based ligand design; nuclear transporters; protein-protein interactions; structure-guided ligand design. We’ll tell you more about this compound (cas:217192-22-8).

Protein-protein interactions are difficult therapeutic targets, and inhibiting pathol. relevant interactions without disrupting other essential ones presents an addnl. challenge. Herein the authors report how this might be achieved for the potential anticancer target, the TPX2-importin-α interaction. Importin-α is a nuclear transport protein that regulates the spindle assembly protein TPX2. It has two binding sites-major and minor-to which partners bind. Most nuclear transport cargoes use the major site, whereas TPX2 binds principally to the minor site. Fragment-based approaches were used to identify small mols. that bind importin-α, and crystallog. studies identified a lead series that was observed to bind specifically to the minor site, representing the first ligands specific for this site. Structure-guided synthesis informed the elaboration of these fragments to explore the source of ligand selectivity between the minor and major sites. These ligands are starting points for the development of inhibitors of this protein-protein interaction.

If you want to learn more about this compound((4-(Pyridin-4-yl)phenyl)methanol)Safety of (4-(Pyridin-4-yl)phenyl)methanol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(217192-22-8).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Suhan, Natalie D.; Allen, Laura; Gharib, Mireille T.; Viljoen, Elizabeth; Vella, Sarah J.; Loeb, Stephen J. researched the compound: (4-(Pyridin-4-yl)phenyl)methanol( cas:217192-22-8 ).Synthetic Route of C12H11NO.They published the article 《Colour coding the co-conformations of a [2]rotaxane flip-switch》 about this compound( cas:217192-22-8 ) in Chemical Communications (Cambridge, United Kingdom). Keywords: color coding co conformations rotaxane flip switch; crystal structure rotaxane flip switch; visible absorption spectra rotaxane flip switch. We’ll tell you more about this compound (cas:217192-22-8).

Fine-tuning the charge transfer chromophores in a series of [2]rotaxane flip-switches yields a unique optical signal (purple color) for one of the interactions allowing for facile determination of the position of the flip-switch equilibrium

If you want to learn more about this compound((4-(Pyridin-4-yl)phenyl)methanol)Synthetic Route of C12H11NO, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(217192-22-8).

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

HPLC of Formula: 217192-22-8. Aromatic heterocyclic compounds can also be classified according to the number of heteroatoms contained in the heterocycle: single heteroatom, two heteroatoms, three heteroatoms and four heteroatoms. Compound: (4-(Pyridin-4-yl)phenyl)methanol, is researched, Molecular C12H11NO, CAS is 217192-22-8, about A Switchable Catalyst Duo for Acyl Transfer Proximity Catalysis and Regulation of Substrate Selectivity. Author is Goswami, Abir; Gaikwad, Sudhakar; Schmittel, Michael.

Enzymes are encoded with a gamut of information to catalyze a highly selective transformation by selecting the proper reactants from an intricate mixture of constituents. Mimicking biol. machinery, two switchable catalysts with differently sized cavities and allosteric control are conceived that allow complementary size-selective acyl transfer in an on/off manner by modulating the effective local concentration of the substrates. Selective activation of one of two catalysts in a mixture of reactants of similar reactivity enabled upregulation of the desired product.

Here is a brief introduction to this compound(217192-22-8)HPLC of Formula: 217192-22-8, if you want to know about other compounds related to this compound(217192-22-8), you can read my other articles.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Holvey, Rhian S.; Valkov, Eugene; Neal, David; Stewart, Murray; Abell, Chris published an article about the compound: (4-(Pyridin-4-yl)phenyl)methanol( cas:217192-22-8,SMILESS:OCC1=CC=C(C2=CC=NC=C2)C=C1 ).SDS of cas: 217192-22-8. Aromatic heterocyclic compounds can be classified according to the number of heteroatoms or the size of the ring. The authors also want to convey more information about this compound (cas:217192-22-8) through the article.

Protein-protein interactions are difficult therapeutic targets, and inhibiting pathol. relevant interactions without disrupting other essential ones presents an addnl. challenge. Herein the authors report how this might be achieved for the potential anticancer target, the TPX2-importin-α interaction. Importin-α is a nuclear transport protein that regulates the spindle assembly protein TPX2. It has two binding sites-major and minor-to which partners bind. Most nuclear transport cargoes use the major site, whereas TPX2 binds principally to the minor site. Fragment-based approaches were used to identify small mols. that bind importin-α, and crystallog. studies identified a lead series that was observed to bind specifically to the minor site, representing the first ligands specific for this site. Structure-guided synthesis informed the elaboration of these fragments to explore the source of ligand selectivity between the minor and major sites. These ligands are starting points for the development of inhibitors of this protein-protein interaction.

Here is just a brief introduction to this compound(217192-22-8)SDS of cas: 217192-22-8, more information about the compound((4-(Pyridin-4-yl)phenyl)methanol) is in the article, you can click the link below.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: (4-(Pyridin-4-yl)phenyl)methanol( cas:217192-22-8 ) is researched.Recommanded Product: 217192-22-8.Chenge, Jude T.; Van Duyet, Le; Swami, Shalini; McLean, Kirsty J.; Kavanagh, Madeline E.; Coyne, Anthony G.; Rigby, Stephen E. J.; Cheesman, Myles R.; Girvan, Hazel M.; Levy, Colin W.; Rupp, Bernd; von Kries, Jens P.; Abell, Chris; Leys, David; Munro, Andrew W. published the article 《Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1》 about this compound( cas:217192-22-8 ) in Journal of Biological Chemistry. Keywords: high throughput screening ligand recognition cytochrome CYP126A1 crystal structure; CYP126A1; Mycobacterium tuberculosis; cytochrome P450; electron paramagnetic resonance (EPR); enzyme structure; high throughput screening (HTS); mass spectrometry (MS); redox potentiometry. Let’s learn more about this compound (cas:217192-22-8).

The Mycobacterium tuberculosis H37Rv genome encodes 20 cytochromes P 450, including P450s crucial to infection and bacterial viability. Many M. tuberculosis P450s remain uncharacterized, suggesting that their further anal. may provide new insights into M. tuberculosis metabolic processes and new targets for drug discovery. CYP126A1 is representative of a P 450 family widely distributed in mycobacteria and other bacteria. Here we explore the biochem. and structural properties of CYP126A1, including its interactions with new chem. ligands. A survey of azole antifungal drugs showed that CYP126A1 is inhibited strongly by azoles containing an imidazole ring but not by those tested containing a triazole ring. To further explore the mol. preferences of CYP126A1 and search for probes of enzyme function, we conducted a high throughput screen. Compounds containing three or more ring structures dominated the screening hits, including nitroarom. compounds that induce substrate-like shifts in the heme spectrum of CYP126A1. Spectroelectrochem. measurements revealed a 155-mV increase in heme iron potential when bound to one of the newly identified nitroarom. drugs. CYP126A1 dimers were observed in crystal structures of ligand-free CYP126A1 and for CYP126A1 bound to compounds discovered in the screen. However, ketoconazole binds in an orientation that disrupts the BC-loop regions at the P 450 dimer interface and results in a CYP126A1 monomeric crystal form. Structural data also reveal that nitroarom. ligands “”moonlight”” as substrates by displacing the CYP126A1 distal water but inhibit enzyme activity. The relatively polar active site of CYP126A1 distinguishes it from its most closely related sterol-binding P450s in M. tuberculosis, suggesting that further investigations will reveal its diverse substrate selectivity.

Here is just a brief introduction to this compound(217192-22-8)Recommanded Product: 217192-22-8, more information about the compound((4-(Pyridin-4-yl)phenyl)methanol) is in the article, you can click the link below.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Recommanded Product: (4-(Pyridin-4-yl)phenyl)methanol. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: (4-(Pyridin-4-yl)phenyl)methanol, is researched, Molecular C12H11NO, CAS is 217192-22-8, about Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl. Author is Iwamura, Ryo; Tanaka, Masayuki; Okanari, Eiji; Kirihara, Tomoko; Odani-Kawabata, Noriko; Shams, Naveed; Yoneda, Kenji.

EP2 receptor agonists are expected to be effective ocular hypotensive agents; however, it has been suggested that agonism to other EP receptor subtypes may lead to undesirable effects. Through medicinal chem. efforts, we identified a scaffold bearing a (pyridin-2-ylamino)acetic acid moiety as a promising EP2-selective receptor agonist. (6-((4-(Pyrazol-1-yl)benzyl)(pyridin-3-ylsulfonyl)aminomethyl)pyridin-2-ylamino)acetic acid 13ax (omidenepag, OMD) exerted potent and selective activity toward the human EP2 receptor (h-EP2). Low doses of omidenepag iso-Pr (OMDI), a prodrug of 13ax, lowered intraocular pressure (IOP) in ocular normotensive monkeys. OMDI was selected as a clin. candidate for the treatment of glaucoma.

Compound(217192-22-8)Recommanded Product: (4-(Pyridin-4-yl)phenyl)methanol received a lot of attention, and I have introduced some compounds in other articles, similar to this compound((4-(Pyridin-4-yl)phenyl)methanol), if you are interested, you can check out my other related articles.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider